SCHEMBL4182979

SCHEMBL4182979

O=C1SCCN1Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.57
GSK3A P49840 3/20 0.50
GSK3B P49841 3/20 0.50
DDB1 Q16531 1/20 0.49
CRBN Q96SW2 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 4/20 0.46
SIGMAR1 Q99720 1/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
F2 P00734 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9743263 0.85 GRM2 (0.54) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL9514131 0.85 ALDH1A1 (0.60) MAPK1ALDH1A1SIGMAR1MAPTHPGD
SCHEMBL9742828 0.82 ALDH1A1 (0.52) ALDH1A1SIGMAR1HPGDKDM4ELMNA
SCHEMBL28958322 0.82 ALDH1A1 (0.50) MAPK1KMT2APOLBALDH1A1KDM4E
SCHEMBL9511632 0.82 HTT (0.59) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL25002012 0.81 CHRNA1 (0.60) MAPK1GSK3AGSK3BDDB1CRBN
Bromide SCHEMBL9512786 0.80 CHRNA1 (0.59) MAPK1GSK3AGSK3BDDB1CRBN
SCHEMBL9512683 0.80 HTT (0.61) POLBCYP2D6CYP2C19ALDH1A1SIGMAR1
SCHEMBL9741850 0.78 ALDH1A1 (0.49) L3MBTL1POLBALDH1A1KDM4E
SCHEMBL9743824 0.78 ALDH1A1 (0.44) MAPK1KMT2AMEN1CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994014784-A1 NEW THIAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF Richter Gedeon Vegyészeti Gyár Rt. (HU) 1994-07-07 WO claimed
EP-0320910-B1 2-Thiazolidinone derivatives, pharmaceutical compositions containing them, process for preparing same, and use RICHTER GEDEON VEGYESZET (HU) 1993-12-08 EP claimed
US-4937252-A 2-thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1990-06-26 US claimed
EP-0320910-A1 2-Thiazolidinone derivatives, pharmaceutical compositions containing them, process for preparing same, and use RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1989-06-21 EP claimed
JP-2000279-A None JP disclosed
CN-120157868-A Thiazolidine ketone-based surfactant and preparation and application thereof 南通理工学院 2025-06-17 CN disclosed
CN-110294719-B Synthesis method of thiazolidone compound 五邑大学 2023-02-28 CN disclosed
WO-2015027307-A1 BENZYLTHIAZOLIDINONE DERIVATIVES USEFUL FOR THE TREATMENT OF SCHIZOPHRENIA UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL-UFRGS (BR) 2015-03-05 WO disclosed
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed
US-20090216024-A1 Processes for making pioglitazone and compounds of the processes ZHU JIE 2009-08-27 US disclosed
US-7541470-B2 Processes for making pioglitazone and compounds of the processes SYNTHON IP INC. (US) 2009-06-02 US disclosed
WO-2005080387-A2 PROCESSES FOR MAKING PIOGLITAZONE AND COMPOUNDS OF THE PROCESSES SYNTHON B.V. (NL) 2005-09-01 WO disclosed
CN-1644579-A N-alkoxide oxo-2-triazolidone derivative, its preparation and use UNIV ZHEJIANG POLYTECHNIC (CN) 2005-07-27 CN disclosed
WO-1994014784-A1 NEW THIAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF Richter Gedeon Vegyészeti Gyár Rt. (HU) 1994-07-07 WO disclosed
WO-1994014784-A1 NEW THIAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF Richter Gedeon Vegyészeti Gyár Rt. (HU) 1994-07-07 WO disclosed
EP-0320910-B1 2-Thiazolidinone derivatives, pharmaceutical compositions containing them, process for preparing same, and use RICHTER GEDEON VEGYESZET (HU) 1993-12-08 EP disclosed
US-4937252-A 2-thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1990-06-26 US disclosed
JP-H02279-A 2-THIAZOLIDINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEN AND THEIR PREPARATION RICHTER GEDEON V G RT 1990-01-05 JP disclosed
EP-0320910-A1 2-Thiazolidinone derivatives, pharmaceutical compositions containing them, process for preparing same, and use RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1989-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090216024-A1 Processes for making pioglitazone and compounds of the processes PDK4, PDK2, DPP4 MAPK1 3882/4885GSK3A 163/4885GSK3B 130/4885
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD MAPK1 1532/4885GSK3A 4410/4885GSK3B 4112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.